DK2026832T3 - Kombination af interferon-beta og et cladribin-regime til behandling af multipel sklerose - Google Patents

Kombination af interferon-beta og et cladribin-regime til behandling af multipel sklerose

Info

Publication number
DK2026832T3
DK2026832T3 DK07729448.6T DK07729448T DK2026832T3 DK 2026832 T3 DK2026832 T3 DK 2026832T3 DK 07729448 T DK07729448 T DK 07729448T DK 2026832 T3 DK2026832 T3 DK 2026832T3
Authority
DK
Denmark
Prior art keywords
multiple sclerosis
interferon
beta
cladribin
regime
Prior art date
Application number
DK07729448.6T
Other languages
Danish (da)
English (en)
Inventor
Nazih Ammoury
H James Brentzel Jr
Maria Lopez-Bresnahan
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Priority claimed from PCT/EP2007/055013 external-priority patent/WO2007135172A2/en
Application granted granted Critical
Publication of DK2026832T3 publication Critical patent/DK2026832T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07729448.6T 2006-05-24 2007-05-23 Kombination af interferon-beta og et cladribin-regime til behandling af multipel sklerose DK2026832T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114537 2006-05-24
US84547006P 2006-09-18 2006-09-18
PCT/EP2007/055013 WO2007135172A2 (en) 2006-05-24 2007-05-23 Cladribine regimen for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
DK2026832T3 true DK2026832T3 (da) 2012-06-25

Family

ID=37395884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07729448.6T DK2026832T3 (da) 2006-05-24 2007-05-23 Kombination af interferon-beta og et cladribin-regime til behandling af multipel sklerose

Country Status (12)

Country Link
CN (1) CN101500598A (pt)
AT (1) ATE555804T1 (pt)
BR (1) BRPI0710326A2 (pt)
DK (1) DK2026832T3 (pt)
EC (1) ECSP088997A (pt)
ES (1) ES2384399T3 (pt)
MY (1) MY149042A (pt)
NZ (1) NZ572680A (pt)
PT (1) PT2026832E (pt)
RS (1) RS52424B (pt)
SI (1) SI2026832T1 (pt)
UA (1) UA96941C2 (pt)

Also Published As

Publication number Publication date
ATE555804T1 (de) 2012-05-15
UA96941C2 (ru) 2011-12-26
RS52424B (en) 2013-02-28
CN101500598A (zh) 2009-08-05
BRPI0710326A2 (pt) 2011-08-09
NZ572680A (en) 2011-11-25
PT2026832E (pt) 2012-06-01
ECSP088997A (es) 2009-01-30
ES2384399T3 (es) 2012-07-04
SI2026832T1 (sl) 2012-07-31
MY149042A (en) 2013-07-15

Similar Documents

Publication Publication Date Title
WO2007135172A3 (en) Cladribine regimen for treating multiple sclerosis
PH12014502847A1 (en) Combination treatment (eg with abt-072-333) of daas for use in treating hcv
MY162067A (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
UA106756C2 (uk) Генетичні маркери, асоційовані з відповіддю на інтерферон-альфа
PH12014502848A1 (en) Methods for treating hcv comprising at least two direct acting antiviral agent, ribavirin but not interferon
MY172012A (en) Use of dpp iv inhibitors
EP2493464A4 (en) METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS
DK1763356T3 (da) Sammensætning der omfatter et survivinantisenseoligonuckleotid og gemcitabin til behandling af cancer
NI201000105A (es) Régimen de dosificación asociado con ésteres de paliperidona inyectables de acción prolongada.
HK1142270A1 (en) Silibinin component for the treatment of hepatitis
TW200630105A (en) Herbal composition PHY906 and its use in chemotherapy
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
MX2012006734A (es) Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de obesidad y otras enfermedades metabolicas.
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
HK1114769A1 (en) Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivative
NO20072285L (no) S-mirtazapin for behandling av hetetokter
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
MX2022000394A (es) Combinaciones terapeuticas de paclitaxel oralmente administrado y un inhibidor de la bomba de p-glicoproteina (p-gp) para el tratamiento del cancer.
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
DK2026832T3 (da) Kombination af interferon-beta og et cladribin-regime til behandling af multipel sklerose
SG146498A1 (en) Compositions for treatment of patients with neurological disorders and cerebral infarction
UA110795C2 (uk) Спосіб лікування раку підшлункової залози
RU2012158011A (ru) Метод и композиция для лечения рака
MY174803A (en) Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug